- Home
- NFBK vs DNA Comparison
NFBK vs DNA Comparison
Compare NFBK & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFBK
- DNA
- Stock Information
- Founded
- NFBK 1887
- DNA 2008
- Country
- NFBK United States
- DNA United States
- Employees
- NFBK N/A
- DNA N/A
- Industry
- NFBK Major Banks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NFBK Finance
- DNA Health Care
- Exchange
- NFBK Nasdaq
- DNA Nasdaq
- Market Cap
- NFBK 559.9M
- DNA 542.6M
- IPO Year
- NFBK 2007
- DNA N/A
- Fundamental
- Price
- NFBK $12.77
- DNA $9.36
- Analyst Decision
- NFBK Hold
- DNA Hold
- Analyst Count
- NFBK 2
- DNA 6
- Target Price
- NFBK $13.63
- DNA $37.80
- AVG Volume (30 Days)
- NFBK 137.5K
- DNA 1.3M
- Earning Date
- NFBK 01-22-2025
- DNA 11-12-2024
- Dividend Yield
- NFBK 4.05%
- DNA N/A
- EPS Growth
- NFBK N/A
- DNA N/A
- EPS
- NFBK 0.64
- DNA N/A
- Revenue
- NFBK $124,553,000.00
- DNA $217,951,000.00
- Revenue This Year
- NFBK N/A
- DNA N/A
- Revenue Next Year
- NFBK $14.71
- DNA N/A
- P/E Ratio
- NFBK $20.08
- DNA N/A
- Revenue Growth
- NFBK N/A
- DNA N/A
- 52 Week Low
- NFBK $6.98
- DNA $5.26
- 52 Week High
- NFBK $14.39
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- NFBK 45.94
- DNA 51.43
- Support Level
- NFBK $12.72
- DNA $9.01
- Resistance Level
- NFBK $13.26
- DNA $11.68
- Average True Range (ATR)
- NFBK 0.42
- DNA 1.00
- MACD
- NFBK -0.09
- DNA -0.08
- Stochastic Oscillator
- NFBK 17.27
- DNA 30.87
About NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.